Conference
Vedolizumab for Moderate to Severely Active Inflammatory Bowel Disease: A Multicenter U.S. Consortium
Authors
Dulai PS; Singh S; Narula N; Peerani F; Whitehead DA; Hudesman D; Kane S; Siegel CA; Sands BE; Colombel J-F
Volume
110
Publisher
Wolters Kluwer
Publication Date
October 1, 2015
DOI
10.14309/00000434-201510001-01904
Conference proceedings
The American Journal of Gastroenterology
ISSN
0002-9270